BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 24949541)

  • 1. Risk of selected structural abnormalities in infants after increased nuchal translucency measurement.
    Baer RJ; Norton ME; Shaw GM; Flessel MC; Goldman S; Currier RJ; Jelliffe-Pawlowski LL
    Am J Obstet Gynecol; 2014 Dec; 211(6):675.e1-19. PubMed ID: 24949541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11-13 weeks.
    Syngelaki A; Chelemen T; Dagklis T; Allan L; Nicolaides KH
    Prenat Diagn; 2011 Jan; 31(1):90-102. PubMed ID: 21210483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of critical congenital heart defects by nuchal translucency norms.
    Jelliffe-Pawlowski LL; Norton ME; Shaw GM; Baer RJ; Flessel MC; Goldman S; Currier RJ
    Am J Obstet Gynecol; 2015 Apr; 212(4):518.e1-10. PubMed ID: 25448520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin edema in first trimester fetuses.
    Jenewein N; Christ J; Günther D; Hutsteiner P; Ortmann O; Germer U
    Ultraschall Med; 2013 Oct; 34(5):441-5. PubMed ID: 23696062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Birth defects associated with increased nuchal translucency].
    Mendoza-Caamal EC; Grether-González P; Hernández-Gómez M; Guzmán-Huerta M; Aguinaga-Ríos M
    Ginecol Obstet Mex; 2010 Oct; 78(10):533-9. PubMed ID: 21966770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated first-trimester nuchal translucency increases the risk of congenital heart defects.
    Bahado-Singh RO; Wapner R; Thom E; Zachary J; Platt L; Mahoney MJ; Johnson A; Silver RK; Pergament E; Filkins K; Hogge WA; Wilson RD; Jackson LG;
    Am J Obstet Gynecol; 2005 May; 192(5):1357-61. PubMed ID: 15902108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal sonographic features of triploidy at 12-16 weeks.
    Zalel Y; Shapiro I; Weissmann-Brenner A; Berkenstadt M; Leibovitz Z; Bronshtein M
    Prenat Diagn; 2016 Jul; 36(7):650-5. PubMed ID: 27135789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuchal translucency measurement and congenital heart defects: modest association in low-risk pregnancies.
    Müller MA; Clur SA; Timmerman E; Bilardo CM
    Prenat Diagn; 2007 Feb; 27(2):164-9. PubMed ID: 17238215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Umbilical cord diameter at 11-14 weeks of gestation: relationship to nuchal translucency, ductus venous blood flow and chromosomal defects.
    Axt-Fliedner R; Schwarze A; Kreiselmaier P; Krapp M; Smrcek J; Diedrich K
    Fetal Diagn Ther; 2006; 21(4):390-5. PubMed ID: 16757918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there still a role for nuchal translucency measurement in the changing paradigm of first trimester screening?
    Bardi F; Bosschieter P; Verheij J; Go A; Haak M; Bekker M; Sikkel E; Coumans A; Pajkrt E; Bilardo C
    Prenat Diagn; 2020 Jan; 40(2):197-205. PubMed ID: 31697852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural heart defects associated with an increased nuchal translucency: 9 years experience in a referral centre.
    Clur SA; Mathijssen IB; Pajkrt E; Cook A; Laurini RN; Ottenkamp J; Bilardo CM
    Prenat Diagn; 2008 Apr; 28(4):347-54. PubMed ID: 18382996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuchal translucency thickness in euploid fetuses: is two millimeters too risky?
    Fink M; Sheiner E; Sheizaf B; Hershkovitz R; Bashiri A; Mazor M; Wiznitzer A
    Am J Perinatol; 2009 Apr; 26(4):303-7. PubMed ID: 19031359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome in apparently healthy children with increased nuchal translucency in the first trimester screening.
    Äyräs O; Eronen M; Tikkanen M; Rahkola-Soisalo P; Paavonen J; Stefanovic V
    Acta Obstet Gynecol Scand; 2016 May; 95(5):541-6. PubMed ID: 26918672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is nuchal translucency a useful aneuploidy marker in fetuses with crown-rump length of 28-44 mm?
    Grande M; Solernou R; Ferrer L; Borobio V; Jimenez JM; Bennasar M; Soler A; Borrell A
    Ultrasound Obstet Gynecol; 2014 May; 43(5):520-4. PubMed ID: 24006271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
    Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
    Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased nuchal translucency and normal karyotype: perinatal and pediatric outcomes at 2 years of age.
    Mula R; Goncé A; Bennásar M; Arigita M; Meler E; Nadal A; Sánchez A; Botet F; Borrell A
    Ultrasound Obstet Gynecol; 2012 Jan; 39(1):34-41. PubMed ID: 21837766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do early pregnancy ultrasound measurements correlate with fetal nuchal translucency at 11-14 weeks?
    Prefumo F; Condous G; Papageorghiou A; Thilaganathan B; Bourne T
    Ultrasound Obstet Gynecol; 2006 Jun; 27(6):628-31. PubMed ID: 16514621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ultrasound soft markers and fetal cardiac structural assessment at 11-14 weeks].
    Yang Y; Zhang Y
    Zhonghua Fu Chan Ke Za Zhi; 2014 Mar; 49(3):188-92. PubMed ID: 24820303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Increased nuchal translucency and cystic hygroma in the first trimester: prenatal diagnosis and neonatal outcome].
    Ducarme G; Graesslin O; Alanio E; Bige V; Gaillard D; Gabriel R
    Gynecol Obstet Fertil; 2005 Oct; 33(10):750-4. PubMed ID: 16139544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuchal translucency and nasal bone for trisomy 21 screening: single center experience.
    Monni G; Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C
    Croat Med J; 2005 Oct; 46(5):786-91. PubMed ID: 16158472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.